$复星医药(SH600196)$ 

出公告了，MPP官网链接如下：35 generic manufacturers sign agreements with MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for supply in 95 low- and middle-income countries - MPP (medicinespatentpool.org)